Join us on January 21st as our expert panel gives an overview of what we have learned over the last 12 months about COVID-19, followed by a discussion focused on differentiating fact from fiction while covering these 3 areas:
- The clinical significance of the emerging new variants
- The treatment: what works what does not work today
- The vaccine, including:
- FDA timeline for granting EUA
- Procurement/distribution/chain of custody: role of DoD/CDC vs. local authorities and perception of “bottleneck"
- Different vaccines available (advantages/disadvantages); pipeline
- Priority for receipt, community compliance, value if previous infection
- Adverse reaction(s), contraindications
Speakers:
- Robert L. Quigley, M.D., D. Phil, Professor of Surgery, Senior Vice President and Global Medical Director, Corporate Health Solutions, International SOS & MedAire, Americas Region,
- Barbara Pahud, MD, MPH, Associate Professor of Pediatrics, Director of Infectious Diseases Research, UMKC School of Medicine
- Dr. Matthew Hepburn, Vaccine Development Lead, Operation Warp Speed, Department of Defense